Yukiko Yamamoto Selected Research

Rodent Diseases

1/2022

Investigating the Therapeutic Potential of LSD1 Enzyme Activity-Specific Inhibition by TAK-418 for Social and Memory Deficits in Rodent Disease Models.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yukiko Yamamoto Research Topics

Disease

9	Neoplasms (Cancer) 01/2021 - 09/2012
2	Hypoxia (Hypoxemia) 04/2017 - 05/2016
2	Brain Injuries (Brain Injury) 04/2017 - 05/2016
2	Medulloblastoma 09/2012 - 09/2012
1	Neurodevelopmental Disorders 01/2022
1	Thrombocytopenia (Thrombopenia) 01/2022
1	Memory Disorders (Memory Loss) 01/2022
1	Rodent Diseases 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 07/2017
1	Obesity 01/2017
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 05/2016
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2013
1	Hyperlipidemias (Hyperlipidemia) 01/2010
1	Fibrosis (Cirrhosis) 10/2008
1	Muscular Dystrophies (Muscular Dystrophy) 01/2008
1	Rhabdomyolysis 11/2005
1	Muscular Diseases (Myopathy) 11/2005
1	Stroke (Strokes) 06/2003

Drug/Important Bio-Agent (IBA)

5	Fatty Acids (Saturated Fatty Acids)IBA 01/2021 - 01/2010
4	Malonyl Coenzyme A (Malonyl CoA)IBA 01/2021 - 01/2018
2	EnzymesIBA 01/2022 - 07/2017
2	stearoyl-coenzyme A (stearoyl-CoA)IBA 07/2017 - 01/2017
2	Isoflurane FDA LinkGeneric 04/2017 - 05/2016
2	Messenger RNA (mRNA)IBA 09/2012 - 09/2012
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Lysine (L-Lysine)FDA Link 01/2022
1	TAK-418IBA 01/2022
1	Amyloid (Amyloid Fibrils)IBA 01/2022
1	RNA Precursors (Precursor, mRNA)IBA 01/2018
1	T-3764518IBA 07/2017
1	oleoyl-coenzyme AIBA 07/2017
1	LipidsIBA 07/2017
1	Stearoyl-CoA DesaturaseIBA 07/2017
1	N(1)-methyl-2-lysergic acid diethylamide (MIL)IBA 04/2017
1	Milrinone (Primacor)FDA LinkGeneric 04/2017
1	salicylhydroxamic acid (SHAM)IBA 04/2017
1	Neuroprotective AgentsIBA 04/2017
1	T-3861174IBA 01/2017
1	Dobutamine FDA LinkGeneric 05/2016
1	2-MethoxyestradiolIBA 05/2016
1	T-2 Toxin (T 2 Toxin)IBA 01/2013
1	Transcription Factors (Transcription Factor)IBA 09/2012
1	Antineoplastic Agents (Antineoplastics)IBA 09/2012
1	Sucrose (Saccharose)IBA 01/2010
1	Macrophage Colony-Stimulating Factor Receptor (Receptor, Macrophage Colony Stimulating Factor)IBA 10/2008
1	CollagenIBA 10/2008
1	Connective Tissue Growth FactorIBA 10/2008
1	Laminin (Merosin)IBA 01/2008
1	3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA)IBA 11/2005
1	Fibric Acids (Fibrates)IBA 11/2005
1	Oxidoreductases (Dehydrogenase)IBA 11/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2005
1	NG-Nitroarginine Methyl Ester (L-NAME)IBA 06/2003

Therapy/Procedure

4	Oral Administration 01/2021 - 01/2018
4	Therapeutics 12/2019 - 01/2008